Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2007

01-05-2007 | Special Article

Treatment guidelines in ovarian cancer

Authors: A. Poveda Velasco, A. Casado Herráez, A. Cervantes Ruipérez, D. Gallardo Rincón, E. García García, A. González Martín, G. López García, C. Mendiola Fernández, B. Ojeda González

Published in: Clinical and Translational Oncology | Issue 5/2007

Login to get access
Metadata
Title
Treatment guidelines in ovarian cancer
Authors
A. Poveda Velasco
A. Casado Herráez
A. Cervantes Ruipérez
D. Gallardo Rincón
E. García García
A. González Martín
G. López García
C. Mendiola Fernández
B. Ojeda González
Publication date
01-05-2007
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-007-0058-8

Other articles of this Issue 5/2007

Clinical and Translational Oncology 5/2007 Go to the issue

Educational Series

Molecular determinants of invasion in endometrial cancer

Review

Oxycodone: a pharmacological and clinical review

Case Reports

False-positive β-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease

Case Reports

Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia

News and Views

High tension: oncologic pain

Research Articles

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits